Cyclo Therapeutics Inc (CYTH)
0.7216
-0.03
(-3.53%)
USD |
NASDAQ |
Nov 01, 16:00
0.7228
0.00 (0.00%)
Pre-Market: 20:00
Cyclo Therapeutics Debt to Equity Ratio: -0.5292 for June 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2024 | -0.5292 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.0097 |
| September 30, 2021 | 0.0199 |
| June 30, 2021 | 0.0142 |
| March 31, 2021 | 0.0111 |
| December 31, 2020 | 0.0152 |
| September 30, 2020 | -0.3022 |
| June 30, 2020 | -0.0826 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| Date | Value |
|---|---|
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.2579 |
| June 30, 2016 | 0.179 |
| March 31, 2016 | 0.2331 |
| December 31, 2015 | 0.1969 |
| September 30, 2015 | 0.1562 |
| June 30, 2015 | 0.2103 |
| March 31, 2015 | 0.195 |
| December 31, 2014 | 0.1818 |
| September 30, 2014 | 0.1755 |
| June 30, 2014 | 0.262 |
| March 31, 2014 | 0.3645 |
| December 31, 2013 | 0.4745 |
| September 30, 2013 | 0.4811 |
| June 30, 2013 | 0.4697 |
| March 31, 2013 | 0.5681 |
| December 31, 2012 | 0.6367 |
| September 30, 2012 | 0.6149 |
| June 30, 2012 | 0.6256 |
| March 31, 2012 | 0.6097 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-0.5292
Minimum
Jun 2024
0.0199
Maximum
Sep 2021
-0.0444
Average
--
Median
Dec 2019
Debt to Equity Ratio Benchmarks
| Stryker Corp | 0.7685 |
| Biogen Inc | 0.3847 |
| Pfizer Inc | 0.7831 |
| Pacira BioSciences Inc | 0.6702 |
| Moderna Inc | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 4.718M |
| Total Liabilities (Quarterly) | 9.841M |
| Shareholders Equity (Quarterly) | -5.123M |
| Current Ratio | 0.4528 |
| Net Debt Paydown Yield | -1.49% |